Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's DiseaseCatherine M. Bollard, Helen E. Heslop, Melissa M. Hudson et al.|The Journal of Experimental Medicine|2004Cited by 390
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Anne Aupérin et al.|New England Journal of Medicine|2020Cited by 308
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKris M. Mahadeo, Sajad Khazal, Hisham Abdel‐Azim et al.|Nature Reviews Clinical Oncology|2018Cited by 236
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)Ankit Kansagra, Shahrukh K. Hashmi, Noelle V. Frey et al.|Bone Marrow Transplantation|2019Cited by 119
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular TherapyAnkit Kansagra, Shahrukh K. Hashmi, Noelle V. Frey et al.|Biology of Blood and Marrow Transplantation|2018Cited by 106